Literature DB >> 7936656

Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.

H Harada1, T Kondo, S Ogawa, T Tamura, M Kitagawa, N Tanaka, M S Lamphier, H Hirai, T Taniguchi.   

Abstract

The transcription factor IRF-1 has been shown to function as a tumor suppressor. Here we report that a significant proportion of the IRF-1 mRNA detected in normal human hematopoietic cells and cultured cell lines lacks exon 2 (containing the AUG initiation codon) and 3 as a result of exon skipping. Surprisingly, when we examined the bone marrow and peripheral mononuclear cells from patients with myelodysplastic syndrome (MDS) or leukemia secondary to MDS, we could still detect the exon-skipped form but little or none of the intact IRF-1 mRNA. This appears to be the result of accelerated exon skipping since we could find no mutations within the exons and splicing junctions from these patients. The exon-skipped form of IRF-1 lacking exons 2 and 3 displayed neither DNA binding nor tumor suppressive activities. Thus this accelerated exon skipping may cause the inactivation of IRF-1 and thereby contribute to the development of human hematopoietic malignancies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936656

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene.

Authors:  A Y Karpova; P M Howley; L V Ronco
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

2.  Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer.

Authors:  Rajendra Karki; Bhesh Raj Sharma; Ein Lee; Balaji Banoth; R K Subbarao Malireddi; Parimal Samir; Shraddha Tuladhar; Harisankeerth Mummareddy; Amanda R Burton; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  JCI Insight       Date:  2020-06-18

3.  Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells.

Authors:  Tomoyuki Ohsugi; Kiyoshi Yamaguchi; Chi Zhu; Tsuneo Ikenoue; Kiyoko Takane; Masaru Shinozaki; Giichiro Tsurita; Hideaki Yano; Yoichi Furukawa
Journal:  Oncogene       Date:  2019-07-10       Impact factor: 9.867

4.  Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.

Authors:  Atsuo Yoshino; Yoichi Katayama; Takakazu Yokoyama; Takao Watanabe; Akiyoshi Ogino; Takashi Ota; Chiaki Komine; Takao Fukushima; Kaoru Kusama
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity.

Authors:  R Lin; J Hiscott
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

6.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

Authors:  A B Bianchi; S I Mitsunaga; J Q Cheng; W M Klein; S C Jhanwar; B Seizinger; N Kley; A J Klein-Szanto; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.

Authors:  S Giannouli; D Tzoanopoulos; K Ritis; G Kartalis; H M Moutsopoulos; M Voulgarelis
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

8.  A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation.

Authors:  Guohui Wan; Xiaoxiao Hu; Yunhua Liu; Cecil Han; Anil K Sood; George A Calin; Xinna Zhang; Xiongbin Lu
Journal:  EMBO J       Date:  2013-10-04       Impact factor: 11.598

Review 9.  Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Authors:  Stephanie Beurlet; Christine Chomienne; Rose Ann Padua
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 10.  Regulation of the interferon system and cell growth by the IRF transcription factors.

Authors:  T Taniguchi; H Harada; M Lamphier
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.